Stock Comparison
ABBV vs GSK
AbbVie Inc and GlaxoSmithKline PLC ADR side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$439.97B
$102.57B
P/E (TTM)
70.3
16.2
Forward P/E
17.7
20.7
Price/Sales
6.8
3.1
Price/Book
51.1
4.3
EV/EBITDA
25.8
9.4
Dividend Yield
2.03%
3.43%
Profitability
Net Margin
9.82%
17.78%
Operating Margin
29.77%
25.67%
Return on Equity
62.30%
33.40%
Return on Assets
10.50%
10.00%
Growth (YoY)
Revenue Growth
10.20%
5.30%
Earnings Growth
290.40%
-69.50%
Price & Risk
Beta
0.3
0.3
52-Week High
$263.65
$60.20
52-Week Low
$197.38
$37.85
Analyst Target
$274.36
$58.08
Compare ABBV and GSK your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.